Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NovaMed Pharmaceuticals

Request full access

NovaMed Pharmaceuticals is focused on sales and marketing, register, circulation, manufacture, and R&D through virtual intergration

Baoshan District, ChinaFounded 2005Biotech & Life Sciences

About NovaMed Pharmaceuticals

NovaMed Pharmaceuticals is a leading player in Pakistan's pharmaceutical industry, known for its commitment to trust, excellence, and quality. The company specializes in manufacturing a wide range of innovative and high-quality medicines, catering to both national and multinational companies. NovaMed operates in various therapeutic classes and offers products in diverse dosage forms. The company's business model includes toll manufacturing arrangements, where it partners with renowned local and international companies to produce their pharmaceutical products. This model allows NovaMed to generate revenue through manufacturing contracts and export sales. NovaMed's products are available in Pakistan and several export markets, reflecting its global presence. The company holds several certifications, including ISO 9001:2000, ISO 22000, IS 14000, and CE marking for Tulle, as well as WHO cGMP Pakistan and GMP Nigeria certifications. These certifications underscore NovaMed's commitment to maintaining high manufacturing standards. NovaMed serves a diverse clientele, including 250 satisfied toll partners and 15,000 happy customers, and exports to 8 countries. The company's focus on quality control, research and development, and quality assurance ensures that it continues to meet the needs of its clients and maintain its reputation for excellence.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
8
Open positions
None listed
Dealroom signal
40.5/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Oncology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Apr 2011 $105M $105M SciClone Pharmaceuticals —
SERIES B✓Equity / VC Jan 2008 $14M $55M Eight Roads Ventures · Atlas Venture —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

NovaMed Pharmaceuticals website traffic

Latest recorded traffic for NovaMed Pharmaceuticals is 120 monthly website visits, down 73.9% over the last three months. NovaMed Pharmaceuticals's team declined 11.1% over the past year.

Latest monthly visits120 3-month web change-73.9% 1-year team growth-11.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NovaMed Pharmaceuticals in the Baoshan District ecosystem

Live from Dealroom

The NovaMed Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Other known investors2 additional known investors

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇵🇰 Pakistan71.4%
🇧🇬 Bulgaria14.3%
🇦🇪 United Arab Emirates14.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NovaMed Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NovaMed Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.